Table 1. Analysis of phosphor-MerTK expression in various cancer types.

Tumor type	p-MERTK		Total N
	Negative	Positive	(n=229)
Gastric cancer (GC)	68(78.2%)	17(19.5%)	87
Genitourinary cancer (GU)	44(95.7%)	2(4.3%)	46
Biliary tact cancer (BTC)	13(81.3%)	3(18.7%)	16
Pancreatic cancer	5(100%)	0(0.0%)	5
HCC	13(86.7%)	2(13.3%)	15
Melanoma	6(66.7%)	3(33.3%)	9
Sarcoma	21(72.4%)	8(27.6%)	29
GIST	4(66.7%)	2(33.3%)	6
Small bowel tumor	4(100%)	0(0.0%)	4
Others	11(91.6%)	1(8.3%)	12